Market closed
CareDx/CDNA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CareDx
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
Ticker
CDNA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
639
Website
CareDx Metrics
BasicAdvanced
$1.2B
Market cap
-
P/E ratio
-$3.02
EPS
1.79
Beta
-
Dividend rate
Price and volume
Market cap
$1.2B
Beta
1.79
52-week high
$34.84
52-week low
$4.80
Average daily volume
892K
Financial strength
Current ratio
4.093
Quick ratio
3.766
Long term debt to equity
9.592
Total debt to equity
11.882
Management effectiveness
Return on assets (TTM)
-9.81%
Return on equity (TTM)
-47.66%
Valuation
Price to revenue (TTM)
4.066
Price to book
4.54
Price to tangible book (TTM)
6.59
Price to free cash flow (TTM)
-54.151
Growth
Revenue change (TTM)
-3.95%
Earnings per share change (TTM)
92.22%
3-year revenue growth (CAGR)
5.42%
3-year earnings per share growth (CAGR)
157.27%
What the Analysts think about CareDx
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for CareDx stock.
CareDx Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
CareDx Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
CareDx News
AllArticlesVideos
CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
Accesswire·1 day ago
CareDx Reports Preliminary Financial Results for Third Quarter 2024
Business Wire·2 weeks ago
CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Business Wire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for CareDx stock?
CareDx (CDNA) has a market cap of $1.2B as of October 26, 2024.
What is the P/E ratio for CareDx stock?
The price to earnings (P/E) ratio for CareDx (CDNA) stock is 0 as of October 26, 2024.
Does CareDx stock pay dividends?
No, CareDx (CDNA) stock does not pay dividends to its shareholders as of October 26, 2024.
When is the next CareDx dividend payment date?
CareDx (CDNA) stock does not pay dividends to its shareholders.
What is the beta indicator for CareDx?
CareDx (CDNA) has a beta rating of 1.79. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.